𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The course of hepatitis C virus infection after liver transplantation

✍ Scribed by Cyrille Féray; Michelle Gigou; Didier Samuel; Valérie Paradis; Judith Wilber; Marie France David; Mickey Urdea; Michel Reynes; Christian Bréchot; Henri Bismuth


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
700 KB
Volume
20
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Hepatitis C virus-induced liver disease is becoming a main indication for liver transplantation. Recurrence of hepatitis after transplantation has been reported, but its long-term consequences are unknown. Seventynine patients positive for hepatitis C virus (group 1) and 106 subjects negative for hepatitis C virus antibody (group 2) with a mean follow-up of 4 yr were retrospectively studied by means of serology, nested polymerase chain reaction and branched-DNA technology before and after liver transplantation. The actuarial rates of hepatitis C virus-related acute hepatitis were 72% and 20% at 4 yr in groups 1 and 2, respectively. Progression to chronic active hepatitis occurred in 61% and 36% of the subjects within 3 yr of the onset of recurrent and acquired hepatitis, respectively. No case of acute graft failure and two cases of cirrhosis were related to recurrent or acquired hepatitis C virus liver disease. Hepatitis C virus RNA levels were significantly increased in cases of hepatitis after transplantation. In contrast, the pretransplant hepatitis C virus RNA level was not predictive of recurrence. Our results establish the general persistence of hepatitis C virus infection after liver transplantation, the frequency and the severe course of recurrent liver disease. However, liver transplantation in hepatitis C virus antibody-positive patients still has a good medium-term prognosis.


📜 SIMILAR VOLUMES


Recurrence of hepatitis C virus infectio
✍ Paul Martin; Santiago J. Muñoz; Adrian M. Di Bisceglie; Raphael Rubin; Jeanne G. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB 👁 2 views

## Identification of the hepatitis C virus-the main cause of posttransfusion and sporadic non -A, non-B hepatitisand the development of a diagnostic serological test have allowed us to study possible recurrence of this type of hepatitis after liver transplantation. Six of 34 consecutive transplant

Early recurrence of hepatitis C virus in
✍ Lydia M. Petrovic 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 2 views

1. Early recurrence of hepatitis C is universal. 2. Typical histopathologic features of hepatitis C virus (HCV) and acute allograft rejection (AAR) exist. 3. Early recurrent HCV may be differentiated from AAR. 4. Liver biopsy plays a role in diagnosing HCV and AAR. 5. Risk factors for recurrent HCV

Hepatitis C virus infection and lymphopr
✍ Nizar N. Zein; Rogelio G. Perez; Russel H. Wiesner 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 2 views

with treatment failures moving on to combination therapy (IFN/CMB). The primary difference between the two best strategies (IFN/CBM vs. CMB-G) was that the CMB-G strategy was more successful with those with genotype 1. Thus, the genotyping strategy reached more people with less responsive disease th

Recurrent and new hepatitis C virus infe
✍ James E. Everhart; Yuling Wei; Heather Eng; Michael R. Charlton; David H. Persin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Chronic infection with the hepatitis C virus (HCV) is the most common reason for liver transplantation. We examined the results of laboratory tests for HCV on a cohort of patients who received a liver transplant between 1990 and 1994 at three large centers. Seven hundred twenty-two recipients and 60

Long-term outcome of hepatitis C virus i
✍ K. H. Böker; G. Dalley; M. J. Bahr; H. Maschek; H. L. Tillmann; C. Trautwein; K. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB 👁 2 views

Carrier states without significant laboratory abnormali-We analyzed the long-term clinical course of 71 paties are observed in approximately 16%, biochemical abtients with RNA-positive hepatitis C virus (HCV) infecnormalities without symptoms are seen in 60%, and tion after liver transplantation. Pa

Interferon-α therapy for hepatitis c vir
✍ Teresa L. Wright; Connie Combs; Michael Kim; Linda Ferrell; Peter Bacchetti; Nan 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 793 KB

The aims of this pilot study were to evaluate the safety and efficacy of interferon-alpha 2b for treatment of hepatitis C virus infection in liver transplant recipients, to monitor changes in hepatitis C virus RNA levels with treatment and to determine pretreatment parameters predictive of a complet